Research in CFS pathology, diagnosis and treatment supported with $2.2 million funding.
Griffith University research has calculated the cost of the debilitating illness ME/CFS for the first time in Australia.
Reports that a drug used to treat autoimmune diseases and cancer could also treat Chronic Fatigue Syndrome (CFS) have been refuted by a new Griffith study.
Inspiration, information and empowerment regarding the topic of Chronic Fatigue Syndrome is expected this week with the screening of movie documentary Unrest on the Gold Coast.
In a world first, Gold Coast researchers have made an important breakthrough in understanding the cause of Chronic Fatigue Syndrome.
Chronic Fatigue Syndrome researchers have discovered a cell receptor which could be a key contributing factor to CFS, providing a much clearer picture of how to tackle the debilitating illness.
Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
NHMRC funding will pave the way for diagnostic tools and therapies for ME/CFS.
Griffith University’s bridge across the Smith Street Motorway and the Ian O’Connor Building will be lit in blue to mark International ME/CFS Awareness Day on May 12.
A diagnostic test for Chronic Fatigue Syndrome could be available within five years following the awarding of $4 million in funding to one of Australia’s foremost authorities on the condition.
